This Article Full Text Full Text (PDF) All Versions of this Article: 200504-663OEv1 172/7/798    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernard, G. R. Search for Related Content PubMed PubMed Citation Articles by Bernard, G. R.

Acute Respiratory Distress Syndrome

A Historical Perspective

Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee

Correspondence and requests for reprints should be addressed to Gordon R. Bernard, M.D., Vanderbilt Division of Allergy, Pulmonary and Critical Care Medicine, 1161 21st Avenue South, Room T1218 MCN, Nashville, TN 37232-2650. E-mail: gordon.bernard{at}vanderbilt.edu

ABSTRACT

Though well described even in ancient writings, the acute respiratory distress syndrome (ARDS) gained major medical attention with the availability of mechanical ventilation and establishment of intensive care units. In the 50 years since this beginning there have been remarkable advances in the understanding of the etiology, physiology, histology, and epidemiology of this often lethal complication of common human maladies. Until recently, improvements in outcome have mainly followed improvements in intensive care unit operation and their associated life support systems, and have not come through discoveries made in the course of prospective randomized trials. In spite of the remarkable increase in research focused on ARDS, there remain a large number of unanswered clinical questions that are potentially extremely important with regard to short-term morbidity as well as long-term outcome. The ARDS Clinical Trials Network study of tidal volume has proven that randomized trials in ARDS with positive results are possible even when using difficult primary outcome measures such as mortality or ventilator-free days. Therefore, the rich combination of new trial strategies, potential treatments, experienced investigators, and increasingly standardized routine care set the stage for rapid advances to be made in the short- and long-term outcomes of this devastating syndrome.

Key Words: acute lung injury • acute respiratory distress syndrome • adult respiratory distress syndrome • noncardiogenic pulmonary edema

This article has been cited by other articles:

				C. G. Clement, S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al. Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in Mice Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1322 - 1330. [Abstract] [Full Text] [PDF]

				M. Zambon and J.-L. Vincent Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time Chest, May 1, 2008; 133(5): 1120 - 1127. [Abstract] [Full Text] [PDF]

				U. Holzinger, M. Feldbacher, A. Bachlechner, R. Kitzberger, V. Fuhrmann, and C. Madl Improvement of Glucose Control in the Intensive Care Unit: An Interdisciplinary Collaboration Study Am. J. Crit. Care., March 1, 2008; 17(2): 150 - 156. [Abstract] [Full Text] [PDF]

				T. D. Girard and G. R. Bernard Mechanical Ventilation in ARDS: A State-of-the-Art Review Chest, March 1, 2007; 131(3): 921 - 929. [Abstract] [Full Text] [PDF]

				R. H. Savel, E. B. Goldstein, E. N. Perencevich, and P. B. Angood The iCritical Care Podcast: A Novel Medium for Critical Care Communication and Education J. Am. Med. Inform. Assoc., January 1, 2007; 14(1): 94 - 99. [Abstract] [Full Text] [PDF]

				T. Xu, J. Qiao, L. Zhao, G. Wang, G. He, K. Li, Y. Tian, M. Gao, J. Wang, H. Wang, et al. Acute Respiratory Distress Syndrome Induced by Avian Influenza A (H5N1) Virus in Mice Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1011 - 1017. [Abstract] [Full Text] [PDF]

				J. G. Parambil, J. L. Myers, and J. H. Ryu Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest, August 1, 2006; 130(2): 553 - 558. [Abstract] [Full Text] [PDF]

				R F Miller, E Allen, A Copas, M Singer, and S G Edwards Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy Thorax, August 1, 2006; 61(8): 716 - 721. [Abstract] [Full Text] [PDF]

				E. B. Milbrandt, A. Ishizaka, and D. C. Angus Update in critical care 2005. Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 833 - 841. [Full Text] [PDF]

				M. A. Matthay and E. Abraham beta-Adrenergic Agonist Therapy as a Potential Treatment for Acute Lung Injury Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 254 - 255. [Full Text] [PDF]